Journals / Ankara Üniversitesi Eczacılık Fakültesi Dergisi / 2026 / Cilt: 47 Sayı: 1

GENETIC DIVERSITY OF ACINETOBACTER BAUMANNII STRAINS ISOLATED FROM DIFFERENT HOSPITALS

FARKLI HASTANELERDEN İZOLE EDİLEN ACİNETOBACTER BAUMANNİİ SUŞLARININ GENETİK ÇEŞİTLİLİĞİ

Hilal Basak Erol(ANKARA UNIVERSITY, FACULTY OF PHARMACY, DEPARTMENT OF BASIC PHARMACEUTICAL SCIENCES, DEPARTMENT OF PHARMACEUTICAL MICROBIOLOGY)0000-0002-7943-755X
Banu Kaşkatepe(ANKARA UNIVERSITY, FACULTY OF PHARMACY, PHARMACY PR.)0000-0002-9722-4267
Nurten Altanlar(ANKARA UNIVERSITY, FACULTY OF PHARMACY, PHARMACY PR.)0000-0003-2977-2269
Sulhiye Yıldız(LOKMAN HEKİM ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ)0000-0002-4549-4898
Süleyman Yalçın(T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü Mikrobiyoloji Referans Laboratuvarı ve Biyolojik Ürün Daire Başkanlığı)0000-0003-1434-2717
Pages
104–110
Publication Date
2023-01-20
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study was to aim to identify genetic similarities or dissimilarities among clinical Acinetobacter baumannii (A. baumannii) isolates from four different hospitals.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The genotypic analysis of the strains can provide information to evaluate the genetic relationships among strains and epidemiological investigations, and it is crucial for monitoring their circulation in different geographic regions.
📊
Key Findings & Data:Objective: The genotypic analysis of the strains can provide information to evaluate the genetic relationships among strains and epidemiological investigations, and it is crucial for monitoring their circulation in different geographic regions.
💡
Conclusion & Impact:This study was to aim to identify genetic similarities or dissimilarities among clinical Acinetobacter baumannii (A. baumannii) isolates from four different hospitals.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Acinetobacter baumannii · direnç · ERIC-PCR

Abstract

Objective: The genotypic analysis of the strains can provide information to evaluate the genetic relationships among strains and epidemiological investigations, and it is crucial for monitoring their circulation in different geographic regions. This study was to aim to identify genetic similarities or dissimilarities among clinical Acinetobacter baumannii (A. baumannii) isolates from four different hospitals.

Özet

Amaç: Suşların genotipik analizi, suşlar arasındaki genetik ilişkileri ve epidemiyolojik araştırmaları değerlendirmek için bilgi sağlayabilir ve farklı coğrafi bölgelerdeki dolaşımlarının izlenmesi için önemlidir. Bu çalışma, dört farklı hastaneden elde edilen klinik Acinetobacter baumannii (A. baumannii) izolatları arasındaki genetik benzerlik veya farklılıkları belirlemeyi amaçlamıştır.

🔖

Cite This Article

Erol, H. B., Kaşkatepe, B., Altanlar, N., Yıldız, S., Yalçın, S. (2023). GENETIC DIVERSITY OF ACINETOBACTER BAUMANNII STRAINS ISOLATED FROM DIFFERENT HOSPITALS. Ankara Üniversitesi Eczacılık Fakültesi Dergisi, Cilt: 47 Sayı: 1, 104–110. https://doi.org/10.33483/jfpau.1168215

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (20)

  1. Vincent, J.L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin, C.D., Reinhart, K. (2009). International study of the prevalence and outcomes of infection in intensive care units. Jama, 302(21), 2323-2329. [CrossRef]
  2. Roca, I., Espinal, P., Vila-Farrés, X., Vila, J. (2012). The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace. Frontiers in Microbiology, 3, 148-169. [CrossRef]
  3. Kiyasu, Y., Hitomi, S., Funayama, Y., Saito, K., Ishikawa, H. (2020). Characteristics of invasive Acinetobacter infection: A multicenter investigation with molecular identification of causative organisms. Journal of Infection and Chemotherapy, 26(5), 475-482. [CrossRef]
  4. Lima, W.G., Alves, M.C., Cruz, W.S., Paiva, M.C. (2018). Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat. European Journal of Clinical Microbiology and Infectious Diseases, 37(6), 1009-1019. [CrossRef]
  5. An, J.H., Kim, Y.H., Moon, J.E., Jeong, J.H., Kim, S.H., Kang, S.J., Jang, H.C. (2017). Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: Can it predict and reduce subsequent infections and the use of colistin?. American Journal of Infection Control, 45(6), 667-672. [CrossRef]
  6. Antunes, L.C., Visca, P., Towner, K.J. (2014). Acinetobacter baumannii: evolution of a global pathogen. Pathogens and Disease, 71(3), 292-301. [CrossRef]
  7. Maleki, A., Vandyousefi, J., Mirzaie, Z., Ghafourian, S., Kazemian, H., Sadeghifard, N. (2017). Molecular Analysis of the Isolates of Acinetobacter baumannii isolated from Tehran Hospitals Using ERIC-PCR Method. Modern Medical Laboratory Journal, 1(1), 12-16. [CrossRef]
  8. Aljindan, R., Alsamman, K., Elhadi, N. (2018). ERIC-PCR genotyping of Acinetobacter baumannii isolated from different clinical specimens. Saudi Journal of Medicine and Medical Sciences, 6(1), 13-17. [CrossRef]
  9. Testing EUCAST (2016). EUCAST disk diffusion test manual, version 4.0. [CrossRef]
  10. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 10.0, valid from 2020-01-01. Basel, Switzerland: EUCAST [accessed 15 Mart 2020].
  11. Dorneles, E.M., Santana, J.A., Ribeiro, D., Dorella, F.A., Guimaraes, A.S., Moawad, M.S., Lage, A.P. (2014). Evaluation of ERIC-PCR as genotyping method for Corynebacterium pseudotuberculosis isolates. PLoS One, 9(6), e98758. [CrossRef]
  12. McConnell, M.J., Actis, L., Pachon, J. (2013). Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Review, 37(2), 130-155. [CrossRef]
  13. Fishbain, J., Peleg, A.Y. (2010). Treatment of Acinetobacter infections. Clinical Infectious Diseases, 51(1), 79-84. [CrossRef]
  14. Karaoglan, I., Zer, Y., Bosnak, V.K., Mete, A.O., Namiduru, M. (2013). In vitro synergistic activity of colistin with tigecycline or beta-lactam antibiotic/beta-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii. Journal of International Medical Research, 41(6), 1830-1837. [CrossRef]
  15. Principe, L., D'Arezzo, S., Capone, A., Petrosillo, N., Visca, P. (2009). In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Annals of Clinical Microbiology and Antimicrobials, 8, 18-29. [CrossRef]
  16. Zarifi, E., Ghazalibina, M., Mansouri, S., Morshedi, K., Pourmajed, R., Arfaatabar, M. (2020). Molecular typing of Acinetobacter baumannii clinical strains by enterobacterial repetitive intergenic consensus polymerase chain reaction (ERIC-PCR). Gene Reports, 18, 100542. [CrossRef]
  17. Hazhirkamal, M., Zarei, O., Movahedi, M., Karami, P., Shokoohizadeh, L., Taheri, M. (2021). Molecular typing, biofilm production, and detection of carbapenemase genes in multidrug-resistant Acinetobacter baumannii isolated from different infection sites using ERIC-PCR in Hamadan, west of Iran. BMC pharmacology and toxicology, 22(1), 32-32. [CrossRef]
  18. Falah, F., Shokoohizadeh, L., Adabi, M. (2019). Molecular identification and genotyping of Acinetobacter baumannii isolated from burn patients by PCR and ERIC-PCR. Scars, Burns and Healing, 5, 2059513119831369. [CrossRef]
  19. Gautam, H., Maheshwari, B., Mohapatra, S., Sood, S., Dhawan, B., Kapil, A., Tezpur, B. (2022). Clonal relationship among Acinetobacter baumannii isolates from different clinical specimens by ERIC-PCR. International Journal of Infectious Diseases, 116, S18-S19. [CrossRef]
  20. Lotfi, F., Shojaie, M., Rahbarnia, L., Dehnad, A., Naghili, B., Lotfi, H. (2022). Molecular characterization and genetic diversity of multidrug- and extensively drug-resistant A. baumannii clinical isolates. Gene Reports, 26, 101455. [CrossRef]